Neuberger Berman Group LLC Haemonetics Corp Transaction History
Neuberger Berman Group LLC
- $123 Billion
- Q3 2024
A detailed history of Neuberger Berman Group LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Neuberger Berman Group LLC holds 4,027,103 shares of HAE stock, worth $342 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
4,027,103
Previous 3,833,888
5.04%
Holding current value
$342 Million
Previous $317 Million
2.04%
% of portfolio
0.26%
Previous 0.27%
Shares
32 transactions
Others Institutions Holding HAE
# of Institutions
333Shares Held
54MCall Options Held
689KPut Options Held
345K-
Black Rock Inc. New York, NY5.96MShares$506 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.17MShares$439 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.44MShares$377 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA4.2MShares$357 Million0.06% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.85MShares$242 Million0.14% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $4.36B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...